les publications scientifiques

Les membres de l’Unité de Recherche sur les Biomarqueurs dans la Population Mauritanienne développent une activité scientifique soutenue, illustrée par de nombreuses publications dans des revues internationales à comité de lecture. Ces travaux portent sur la génétique humaine, la biologie moléculaire, l’immunogénétique et la santé des populations, avec un intérêt particulier pour les problématiques biomédicales spécifiques à la Mauritanie.

Les publications ci-dessous témoignent de l’engagement de l’unité dans la production de connaissances scientifiques de qualité et dans le rayonnement académique aux niveaux national et international.

Publications scientifiques (classées par année)

🔹 2026
•⁠ ⁠Ennahoui S.M., Sid M’Hamed A., Veten F., Cheikh Bouna S.M., Barakat A., Soumbara T., Houmeida A.
Impact of TNF-α (−308G>A and −857C>T) promoter variants on susceptibility to chronic hepatitis B virus infection in a cohort of Mauritanian patients: Pilot study.
BMC Microbiology, sous presse, 2026.


🔹 2025
•⁠ ⁠Riahi Z. et al., Houmeida A.
Genetics of prelingual isolated deafness and Usher syndrome in the Maghreb and Jordan: Harnessing the potential of homozygosity.
PNAS, 2025;122(50):e2518445122.
doi:10.1073/pnas.2518445122
•⁠ ⁠Elwafi M., Abdi A., Akhouayri O., Zein A., Houmeida A.
Prevalence and genetic etiology of polycystic ovarian syndrome (PCOS) in Mauritania.
Frontiers in Reproductive Health, 2025;7:1461405.
doi:10.3389/frph.2025.1461405


🔹 2024
•⁠ ⁠Salame M. et al., Houmeida A.
Splice-altering variant of PJVK gene in a Mauritanian family with non-syndromic hearing impairment.
Journal of Applied Genetics, 2024.
doi:10.1007/s13353-024-00903-x
•⁠ ⁠Soumbara T. et al., Houmeida A.
Genetic variation of TLR3 gene is associated with the outcome of hepatitis B infection in Mauritanian patients.
BMC Infectious Diseases, 2024;24:616.
doi:10.1186/s12879-024-09503-w
•⁠ ⁠Soumbara T. et al., Houmeida A.
Implication of isolated anti-HBc antibodies among Mauritanian blood donors.
Teikyo Medical Journal, 2024;47(2).


🔹 2023
•⁠ ⁠Abdelmalick A. et al., Houmeida A. & Ghazal H.
Genomic evidence of multiple introductions of SARS-CoV-2 in Mauritania.
Bioinformatics and Biology Insights, 2023.
doi:10.1177/11779322231167927
•⁠ ⁠Salame M. et al., Houmeida A.
Identification of a novel pathogenic LRTOMT mutation in Mauritanian families with nonsyndromic deafness.
European Archives of Oto-Rhino-Laryngology, 2023.
doi:10.1007/s00405-023-07907-z
•⁠ ⁠Brahim S.M. et al., Houmeida A.
Epidemiological and clinicopathological features of breast cancer in Mauritania.
Academic Journal of Health Sciences, 2023;38(1):120-127.


🔹 2022
•⁠ ⁠Brahim S.M. et al., Houmeida A.
Screening of BRCA1/2 variants in Mauritanian breast cancer patients.
BMC Cancer, 2022;22:802.
doi:10.1186/s12885-022-09903-8
•⁠ ⁠Brahim S.M., Zin E., Houmeida A., Tolba A.
General Oncology Care in Mauritania.
Springer, 2022. ISBN: 978-981-16-7947-6.


🔹 2020
•⁠ ⁠Khiddi F. et al., Houmeida A.
Characteristics of Helicobacter pylori strains isolated from Mauritanian patients.
Helicobacter, 2020;25:e12726.
doi:10.1111/hel.12726


🔹 2019
•⁠ ⁠Hadrami M. et al., Houmeida A.
Mutation profile of glaucoma candidate genes in Mauritanian families with primary congenital glaucoma.
Molecular Vision, 2019;25:373-381.


🔹 2018
•⁠ ⁠Hadrami M. et al., Houmeida A.
A novel missense mutation of GJA8 causes congenital cataract in a large Mauritanian family.
European Journal of Ophthalmology, 2018.
doi:10.1177/1120672118804757
•⁠ ⁠Hamed C.T. et al., Houmeida A.
HLA class I and II polymorphism in the Mauritanian population.
BMC Medical Genetics, 2018;19:2.
doi:10.1186/s12881-017-0514-4


🔹 2016
•⁠ ⁠Delmaghani S. et al., Houmeida A.
Mutations in CDC14A cause autosomal-recessive severe deafness.
American Journal of Human Genetics, 2016.
doi:10.1016/j.ajhg.2016.04.015
•⁠ ⁠Moctar E.C. et al., Houmeida A.
Etiology and GJB2 mutations in Mauritanian children with hearing loss.
European Archives of Oto-Rhino-Laryngology, 2016.


🔹 2015
•⁠ ⁠Veten F. et al., Houmeida A.
Occurrence of the Codon 24 mutation in the Mauritanian population.
Hemoglobin, 2015.
doi:10.3109/03630269.2015.1043060


🔹 2014
•⁠ ⁠Abdelhamid I. et al., Houmeida A.
E23K variant in KCNJ11 associated with type 2 diabetes in Mauritania.
Primary Care Diabetes, 2014.
doi:10.1016/j.pcd.2013.10.006


🔹 2013
•⁠ ⁠Meiloud G. et al., Houmeida A.
Type 2 diabetes in Mauritania: prevalence and maternal effect.
Primary Care Diabetes, 2013.
doi:10.1016/j.pcd.2012.12.002
•⁠ ⁠Hamed C.T. et al., Houmeida A.
Distribution of Rhesus and Kell blood groups in Mauritania.
Blood Transfusion, 2013.


🔹 2012
•⁠ ⁠Veten F.M. et al., Houmeida A.
HbS and β-globin haplotypes in Mauritania.
Hemoglobin, 2012.
•⁠ ⁠Hamed C.T. et al., Houmeida A.
ABO and Rh blood group frequencies in Mauritania.
International Journal of Immunogenetics, 2012.


🔹 2010
•⁠ ⁠Houmeida A. et al.
Mechanism of regulation of cardiac muscle thin filaments.
Journal of Biological Chemistry, 2010.


🔹 2008
•⁠ ⁠Houmeida A. et al.
Evidence for the oligomeric state of elastic titin.
Journal of Molecular Biology, 2008.

Partagez votre amour

Mises à jour de la newsletter

Saisissez votre adresse e-mail ci-dessous et abonnez-vous à notre newsletter

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *